HHTM

DRAPER, UTAH – While corporate Diversity, Equity, and Inclusion (DE&I) efforts may be on the rise, those with hearing loss are a population that continues to be left behind by companies when it comes to providing inclusive healthcare opportunities. According to a new survey1 by TruHearing, only a quarter of employees reported that their employer offers hearing benefits, despite the

LYNGE, DENMARK — Realigning its organizational structure to better serve existing Hearing Care Professionals (HCPs) and their patients in the United States and Canada, while accelerating its development of Latin American business opportunities, WS Audiology today announced the formation of WSA Americas and appointed medical device and WSA veteran Carsten Buhl to serve as President of the new regional business

VANCOUVER, WASHINGTON — In a deal underlining the increasing importance of scalable,  digital processes for clinics in the multibillion-dollar allergy space, Audigy Group LLC has sold its comprehensive allergy-management platform, Clarity™, to Xtract Solutions.   The sale, which closed this week, further expands Xtract’s line of cloud-based immunotherapy software and allows Audigy to focus on its core business of audiology and

This week, Ashley Hughes is joined by Audrey Taylor, a clinical audiologist in Texas, to discuss her experience as a student and now as a clinician with hearing loss. Dr. Taylor helped create and develop the Student Academy of Audiology’s resources for students with hearing loss and continues to serve as an advisor to the group. In this episode she

SAN DIEGO, CALIFORNIA — Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that the OTO-313 Phase 2 trial in tinnitus demonstrated no clinically meaningful benefit versus placebo for primary and secondary endpoints across all timepoints. The randomized, double-blind, placebo-controlled Phase 2 trial enrolled 153 patients with persistent, unilateral tinnitus of

SOMERSET, NEW JERSEY – The 2022 Oticon Audiology Summer Camp brought graduate students representing 21 US universities to Orlando, Florida for a 4-day series of lectures and workshops focused on preparing them for success as new professionals in the field of audiology. Launched in 1997, the annual professional development event is designed to supplement and complement students’ education with relevant,

CAMBRIDGE & TOKYO — Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, have announced that the companies have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss. Utilizing Mogrify’s proprietary direct cellular reprogramming platform, the collaboration

SEATTLE, WASHINGTON — Sound Pharmaceuticals has announced that it has enrolled the first patient in its Phase 3 clinical trial involving SPI-1005 for the Treatment of Meniere’s Disease (STOPMD-3). Additionally, this marks the first Phase 3 trial of an investigational new drug for the treatment of Meniere’s Disease (MD). Prior to STOPMD-3, all US based MD trials involved drugs that

ST. PAUL, MINNESOTA — 3M (NYSE: MMM) has announced it is taking action to resolve litigation related to Combat Arms Earplugs Version 2 (“Combat Arms Earplugs”). Aearo Technologies and related entities, all of which are wholly-owned 3M subsidiaries, have voluntarily initiated chapter 11 proceedings seeking court supervision to help establish a trust – funded by 3M – to “efficiently and

Today, Bose Corporation and Lexie Hearing, a direct-to-consumer hearing aid provider in the United States, announced a partnership to bring Bose’s self-fitting hearing aid technology to the Lexie Hearing product line. The new Lexie B1 Hearing Aids will be Powered by Bose, allowing wearers to fit, program, and control their hearing aids “with clinically proven, audiologist-quality results — without a